The outlook for the management of multiple myeloma looks promising as new treatments, including combination therapy options, become more widely available in Australia.

In this webinar Professor Miles Prince and an expert panel from Myeloma Australia’s Medical and Scientific Advisory Group discuss the changing therapeutic landscape in multiple myeloma and what we can expect from these new treatment approaches.

Video

Podcast

Resources and trials discussed in this webinar:

Myeloma Australia website https://myeloma.org.au/

Myeloma Australia MSAG treatment guidelines: https://myeloma.org.au/health-professional-resources/

ALLG clinical trials https://www.allg.org.au/clinical-trials-research/current-clinical-trials/

Hosted by

Professor H. Miles Prince AM. MBBS (Hons) MD FRACP FRCPA AFRCMA MACD FAHMS

Professor, University of Melbourne. Professor, Monash University.

Professor/Director of Molecular Oncology and Cancer Immunology, Epworth Healthcare

Cell Therapies, Peter MacCallum Cancer Centre

With special guests

Associate Professor Hang Quach MBBS (Hons) SpecCertOC FRACP FRCPA MD

Consultant Clinical and Laboratory Haematologist. Director, Haematology Clinical Research and Director, Clinical Haematology Service at St.Vincent’s Hospital. Associate Professor, University of Melbourne.

Dr Silvia Ling MBBS PhD FRACP FRCPA

Conjoint Senior lecturer at The Western Sydney University and The University of NSW. Haematologist, Liverpool Cancer Therapy Centre, Liverpool Hospital and Sydney Adventist Hospital

Dr Bradley Augustson

Haematologist, Sir Charles Gairdner Hospital and Hollywood Private Hospital

Hayley Beer

Manager Programs & Patient Services, Myeloma Australia Myeloma Clinical Nurse Consultant, Peter MacCallum Cancer Centre.

This program was developed independently by the limbic and MSAG. Thanks to Bristol Myers Squibb Australia Pty Ltd for providing a non-restrictive educational grant that made this possible.